120 related articles for article (PubMed ID: 33109543)
1.
Bai L; Li X; Ma X; Zhao R; Wu D
Anticancer Res; 2020 Nov; 40(11):6051-6062. PubMed ID: 33109543
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.
Li X; Gera L; Zhang S; Chen Y; Lou L; Wilson LM; Xie ZR; Sautto G; Liu D; Danaher A; Mamouni K; Yang Y; Du Y; Fu H; Kucuk O; Osunkoya AO; Zhou J; Wu D
Theranostics; 2021; 11(14):6873-6890. PubMed ID: 34093859
[No Abstract] [Full Text] [Related]
3. Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models.
Bai L; Li X; Yang Y; Zhao R; White EZ; Danaher A; Bowen NJ; Hinton CV; Cook N; Li D; Wu AY; Qui M; Du Y; Fu H; Kucuk O; Wu D
Transl Oncol; 2023 Aug; 34():101707. PubMed ID: 37271121
[TBL] [Abstract][Full Text] [Related]
4. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J
Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029
[No Abstract] [Full Text] [Related]
5. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.
Mumenthaler SM; Ng PY; Hodge A; Bearss D; Berk G; Kanekal S; Redkar S; Taverna P; Agus DB; Jain A
Mol Cancer Ther; 2009 Oct; 8(10):2882-93. PubMed ID: 19825806
[TBL] [Abstract][Full Text] [Related]
6. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
[TBL] [Abstract][Full Text] [Related]
8. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
Li X; Chen Y; Bai L; Zhao R; Wu Y; Xie ZR; Wu JM; Bowen NJ; Danaher A; Cook N; Li D; Qui M; Du Y; Fu H; Osunkoya AO; Kucuk O; Wu D
Br J Cancer; 2023 Sep; 129(5):884-894. PubMed ID: 37474721
[TBL] [Abstract][Full Text] [Related]
9. Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
Chen Y; Gera L; Zhang S; Li X; Yang Y; Mamouni K; Wu AY; Liu H; Kucuk O; Wu D
Cancer Lett; 2019 Apr; 446():62-72. PubMed ID: 30660650
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).
Park SR; Lee KD; Kim UK; Gil YG; Oh KS; Park BS; Kim GC
Yonsei Med J; 2010 Sep; 51(5):708-16. PubMed ID: 20635445
[TBL] [Abstract][Full Text] [Related]
11. TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways.
Ye J; Chu C; Chen M; Shi Z; Gan S; Qu F; Pan X; Yang Q; Tian Y; Wang L; Yang W; Cui X
Oncol Rep; 2019 Feb; 41(2):1169-1179. PubMed ID: 30431120
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
Zhang D; Yang XJ; Luo QD; Xue L; Chong T
Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
[TBL] [Abstract][Full Text] [Related]
14. Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways.
Sun YW; Huang WJ; Hsiao CJ; Chen YC; Lu PH; Guh JH
Prostate; 2010 Sep; 70(12):1295-306. PubMed ID: 20623631
[TBL] [Abstract][Full Text] [Related]
15. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
Wang Y; Pei X; Xu P; Tan Z; Zhu Z; Zhang G; Jiang Z; Deng Z
Oncol Rep; 2020 Sep; 44(3):849-862. PubMed ID: 32582990
[TBL] [Abstract][Full Text] [Related]
16. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway.
Johnson JJ; Syed DN; Heren CR; Suh Y; Adhami VM; Mukhtar H
Pharm Res; 2008 Sep; 25(9):2125-34. PubMed ID: 18286356
[TBL] [Abstract][Full Text] [Related]
17. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells.
Chen RJ; Ho YS; Guo HR; Wang YJ
Toxicol Sci; 2010 May; 115(1):118-30. PubMed ID: 20106947
[TBL] [Abstract][Full Text] [Related]
18. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
Zhang Y; Jin Z; Zhou H; Ou X; Xu Y; Li H; Liu C; Li B
Cancer Med; 2016 Jun; 5(6):1251-8. PubMed ID: 26899963
[TBL] [Abstract][Full Text] [Related]
19. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
20. ICAM-1 and AMPK regulate cell detachment and apoptosis by N-methyl-N'-nitro-N-nitrosoguanidine, a widely spread environmental chemical, in human hormone-refractory prostate cancers.
Chen YC; Lu PH; Hsu JL; Yu CC; Guh JH
Toxicol Appl Pharmacol; 2011 Dec; 257(3):412-9. PubMed ID: 22001597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
